Semaglutide (glp-1 Receptor Agonist) Injectable Solution Generics - Manufacturers & Suppliers
Ozempic(EU & US)
| Product/Composition:- | Semaglutide (GLP-1 receptor agonist) Injectable solution |
|---|---|
| Strength:- | 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 2 mg/0.5 mL |
| Form:- | Injectable solution (prefilled pen) |
| Reference Brands:- | Ozempic(EU & US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Semaglutide is a GLP-1 receptor agonist that mimics the action of incretin hormones to enhance insulin secretion, suppress glucagon release, and slow gastric emptying, helping control blood sugar. It is used for type 2 diabetes management and chronic weight control in obese or overweight adults, improving glycemic levels and promoting satiety.
Semaglutide, a GLP-1 receptor agonist available as an injectable solution (e.g., Ozempic, Wegovy), is FDA-approved in the USA for type 2 diabetes and chronic weight management in adults. It requires Boxed Warnings for potential thyroid C-cell tumors and must meet GMP, labeling, and post-marketing surveillance standards. In the EU, semaglutide is centrally approved by the EMA for the same indications, with stringent requirements for Risk Management Plans (RMPs) and pharmacovigilance reporting. Ongoing clinical safety and batch quality oversight are essential in both markets. Explore compliant supply options at Pharmatradz.com.